STRADB antibody (C-Term, Leu289)
Quick Overview for STRADB antibody (C-Term, Leu289) (ABIN2199790)
Target
See all STRADB AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term, Leu289
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- ALS2CR2, CT (L289) (STE20-related Kinase Adapter Protein beta, STRAD beta, Pseudokinase ALS2CR2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 2 Protein, ILP-interacting Protein, CALS-21, STRADB, ILPIP, PRO1038)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogen
- Synthetic peptide selected from the C-terminal region of human ALS2CR2 (KLH).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- STRADB (STE20-Related Kinase Adaptor beta (STRADB))
-
Alternative Name
- ALS2CR2
-
NCBI Accession
- NP_061041
-
UniProt
- Q9C0K7
-
Pathways
- AMPK Signaling
Target
-